1.80
-0.18(-9.09%)
Currency In USD
| Previous Close | 1.98 |
| Open | 1.98 |
| Day High | 2.04 |
| Day Low | 1.74 |
| 52-Week High | 5.92 |
| 52-Week Low | 1.25 |
| Volume | 2M |
| Average Volume | 1.69M |
| Market Cap | 123.27M |
| PE | -2.17 |
| EPS | -0.83 |
| Moving Average 50 Days | 1.71 |
| Moving Average 200 Days | 3.15 |
| Change | -0.18 |
If you invested $1000 in Neuronetics, Inc. (STIM) since IPO date, it would be worth $64.79 as of January 14, 2026 at a share price of $1.8. Whereas If you bought $1000 worth of Neuronetics, Inc. (STIM) shares 5 years ago, it would be worth $122.87 as of January 14, 2026 at a share price of $1.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 20, 2025 1:30 PM GMT
MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the live
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
GlobeNewswire Inc.
Nov 12, 2025 3:33 PM GMT
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 StatesMALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and m
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire Inc.
Oct 30, 2025 12:32 PM GMT
New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA ClinicsMALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a